Pharming Group N.V.
PHARM.AS · AMS
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | €973 | €718 | €562 | €709 |
| - Cash | €132 | €92 | €60 | €55 |
| + Debt | €131 | €128 | €119 | €112 |
| Enterprise Value | €972 | €754 | €621 | €766 |
| Revenue | €97 | €93 | €79 | €93 |
| % Growth | 4.4% | 17.9% | -14.7% | – |
| Gross Profit | €90 | €84 | €71 | €80 |
| % Margin | 92.7% | 90.4% | 89.5% | 86.8% |
| EBITDA | €23 | €10 | -€4 | €16 |
| % Margin | 24.1% | 10.5% | -5.2% | 16.9% |
| Net Income | €8 | €5 | -€15 | €3 |
| % Margin | 7.8% | 5% | -18.6% | 3.1% |
| EPS Diluted | 0.011 | 0.007 | -0.022 | 0.005 |
| % Growth | 61.4% | 131.8% | -558.3% | – |
| Operating Cash Flow | €32 | €12 | €0 | €9 |
| Capital Expenditures | -€0 | -€0 | -€0 | -€0 |
| Free Cash Flow | €32 | €12 | -€0 | €9 |